Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Surveillance, Epidemiology, and End Results Program
  • Home
  • Cancer Statistics
    • Reports on Cancer
      • Annual Report to the Nation on the Status of Cancer
      • Cancer Stat Facts
      • Cancer Statistics Review
      • Preliminary Incidence Rates
      • SEER Publications
    • Interactive Tools, Maps, & Graphs
      • SEER*Explorer
      • CanStat Animator
      • Cancer Query Systems
    • Understanding Statistics
      • Did You Know? Video Series
      • Defining Cancer Statistics
      • Glossary of Statistical Terms
    • SEER Publications
      • Monographs
    • Reports on Cancer
      • Annual Report to the Nation on the Status of Cancer
      • Cancer Stat Facts
      • Cancer Statistics Review
      • Preliminary Incidence Rates
      • SEER Publications
    • Interactive Tools, Maps, & Graphs
      • SEER*Explorer
      • CanStat Animator
      • Cancer Query Systems
    • Understanding Statistics
      • Did You Know? Video Series
      • Defining Cancer Statistics
      • Glossary of Statistical Terms
  • SEER Data & Software
    • SEER Incidence Database
      • Accessing the Data
      • Request the Data
      • Sample Data Use Agreement
    • Documentation for Data
      • SEER*Stat Database Details
      • Variable and Recode Definitions
    • U.S. Datasets
      • U.S. Mortality
      • U.S. Populations
      • Standard Populations
      • SEER Linked Databases
    • Statistical Software
      • SEER*Stat
      • SEER*Prep
      • Methods & Tools for Population-based Cancer Statistics
    • SEER Incidence Database
      • Accessing the Data
      • Request the Data
      • Sample Data Use Agreement
    • Documentation for Data
      • SEER*Stat Database Details
      • Variables and Recode Definitions
    • U.S. Datasets
      • U.S. Mortality
      • U.S. Populations
      • Standard Populations
      • SEER Linked Databases
    • Statistical Software
      • SEER*Stat
      • SEER*Prep
      • Methods & Tools for Population-based Cancer Statistics
  • Registry Operations
    • Reporting Guidelines
      • SEER Program Coding Manual
      • Hematopoietic Project
      • 2018 Solid Tumor Rules
    • Tools & Software
      • Glossary for Registrars
      • SEER*Rx - Drug Database
      • SEER Abstracting Tool
      • SEER Data Management System (SEER*DMS)
    • Questions & Answers
      • SEER Inquiry System
      • Ask a SEER Registrar
      • Data Collection Answers
    • Staging
      • Registrar Staging Assistant (SEER*RSA)
      • Summary Stage 2018
      • Staging Resources
    • Training
    • Reporting Guidelines
      • SEER Program Coding Manual
      • Hematopoietic Project
      • 2018 Solid Tumor Rules
    • Tools & Software
      • Glossary for Registrars
      • SEER*Rx - Drug Database
      • SEER Abstracting Tool
      • SEER Data Management System (SEER*DMS)
    • Questions & Answers
      • SEER Inquiry System
      • Ask a SEER Registrar
      • Data Collection Answers
    • Staging
      • Registrar Staging Assistant (SEER*RSA)
      • Summary Stage 2018
      • Staging Resources

    • Training
  • News
  • About
Return Home Home SEER Site Search

SEER Site Search

WARNING: Index expression(s) match non-prefix substring of term `./kiragans' 
Collection to search


 

Search all Division of Cancer Control & Population Sciences sites (includes SEER and all Surveillance Research Program sites) at CancerControl.cancer.gov.

1 through 10 of 117 matching documents, best matches first.   sort by date
Page: 1 2 3 4 5 6 7 8 9 10   Next >>

Glossary for Registrars
It binds to large molecules in tumor cells that have a low level of oxygen. Radiation given off by 18F-fluoromisonidazole and 18F-MISO (FMISO) is detected by a PET scan. The amount ...
https://seer.cancer.gov/...ry/view/55227dd8e4b0bc5c16c00a78/ - 25K

SEER Hematopoietic and Lymphoid Neoplasm Database
... Laparotomy (rarely performed) Lymph node biopsy MRI (magnetic resonance imaging) PET (positron emission tomography) scan Physical exam and history (H&P) Progression and ...
https://seer.cancer.gov/...melymph/51f6cf56e3e27c3994bd5306/ - 41K

SEER Hematopoietic and Lymphoid Neoplasm Database
... performed) Lymph node biopsy MRI (magnetic resonance imaging) Peripheral blood smear PET (positron emission tomography) scan Physical exam and history (H&P) Progression and ...
https://seer.cancer.gov/...melymph/51f6cf56e3e27c3994bd52fd/ - 46K

SEER Hematopoietic and Lymphoid Neoplasm Database
... Lymph node biopsy MRI (magnetic resonance imaging) Peripheral blood smear PET (positron emission tomography) scan Physical exam and history (H&P) Progression and ...
https://seer.cancer.gov/...melymph/51f6cf59e3e27c3994bd544d/ - 52K

[PDF]  SEER Reliability Study 2019: Appendix 2
from scans in the following priority order: MRI, CT, PET, Angiogram No resection done. ... Mammogram and ultrasound both at 3 o'clock position. PET scan states lower outer quadrant. ...
https://seer.cancer.gov/...ReliabilityStudy-FinalAnswers.pdf - 1.4M

SEER Hematopoietic and Lymphoid Neoplasm Database
... Blood chemistry studies Bone marrow aspiration and biopsy CT (CAT) scan Complete blood count (CBC) Cytogenetic analysis Flow cytometry MRI (magnetic resonance imaging) PET ...
https://seer.cancer.gov/...melymph/51f6cf56e3e27c3994bd5312/ - 43K

SEER Hematopoietic and Lymphoid Neoplasm Database
... Laparotomy (rarely performed) Lymph node biopsy MRI (magnetic resonance imaging) PET (positron emission tomography) scan Physical exam and history (H&P) Progression and ...
https://seer.cancer.gov/...melymph/51f6cf59e3e27c3994bd544a/ - 43K

SEER Hematopoietic and Lymphoid Neoplasm Database
... Laparotomy (rarely performed) Lymph node biopsy MRI (magnetic resonance imaging) PET (positron emission tomography) scan Physical exam and history (H&P) Progression and ...
https://seer.cancer.gov/...melymph/51f6cf59e3e27c3994bd5489/ - 42K

SEER Hematopoietic and Lymphoid Neoplasm Database
... Laparotomy (rarely performed) Lymph node biopsy MRI (magnetic resonance imaging) PET (positron emission tomography) scan Physical exam and history (H&P) Progression and ...
https://seer.cancer.gov/...melymph/51f6cf5ae3e27c3994bd548f/ - 44K

SEER Hematopoietic and Lymphoid Neoplasm Database
... Laparotomy (rarely performed) Lymph node biopsy MRI (magnetic resonance imaging) PET (positron emission tomography) scan Physical exam and history (H&P) Progression and ...
https://seer.cancer.gov/...melymph/51f6cf5ae3e27c3994bd5495/ - 42K

1 through 10 of 117 matching documents, best matches first.   sort by date
Page: 1 2 3 4 5 6 7 8 9 10   Next >>
Return to Top

SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based statistics.

Follow SEER

  • Twitter
  • SRP Blog

Contact Information

  • Contact SEER
  • NCI LiveHelp Online Chat

More Information

  • Careers
  • Sitemap
  • Using This Website

Policies

  • Accessibility
  • Disclaimer
  • FOIA
  • Privacy & Security
  • Reuse of Graphics and Text
  • Website Linking
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Cancer Institute
  • USA.gov

NIH... Turning Discovery Into Health®